Therefore, in the subgroup comparisons of this meta-analysis, the diagnostic value of combined testing of urinary cell cycle arrest biomarkers (TIMP-2/IGFBP7) vs. single-marker testing for pediatric AKI was systematically evaluated. The gene discussed is TIMP2; the disease is acute kidney injury.